---

Clinical Assessment: 65F with Dyspnea + AF with RVR + ST-T Changes

Initial Stabilization Priority

• Acute decompensated heart failure
• Pulmonary embolism
• Sepsis
• Severe hypovolemia
• Cardiac tamponade

---

ECG Interpretation

Critical: ST-T changes in the setting of AF with RVR can be rate-related (resolve with rate control) or indicate true ACS. Obtain troponins and serial ECGs.

---

Immediate Assessment

History & Examination

• Duration of AF (< or >48 hours — critical for cardioversion risk)
• Prior AF history, medications, anticoagulation status
• Signs of hemodynamic instability: hypotension, altered consciousness, pulmonary edema, chest pain
• Signs of heart failure: elevated JVP, S3 gallop, crackles, bilateral leg edema

Investigations (simultaneous with management)

• 12-lead ECG (confirm AF, assess ST changes in multiple leads)
• Troponin I/T (serial — r/o ACS as precipitant)
• CXR (pulmonary congestion, cardiomegaly)
• Echo (LV function, valvular disease, effusion — urgent if unstable)
• BNP/NT-proBNP (heart failure severity)
• CBC, BMP, Mg²⁺ (electrolytes — hypokalemia/hypomagnesemia promote AF)
• TSH (hyperthyroidism — causes AF)
• D-dimer / CT-PA if PE suspected
• ABG if severe respiratory distress

---

Hemodynamic Status Assessment

UNSTABLE (hypotension, severe pulmonary edema, altered consciousness, ongoing ischemia)

• If AF duration >48 hours or unknown and no anticoagulation: give a DOAC dose or LMWH before or immediately after cardioversion if feasible; ideally TEE first if logistically possible
• Treat underlying cause simultaneously

STABLE

---

Rate Control (Stable Patient)

Key rule: AV nodal agents (diltiazem, verapamil, beta-blockers, digoxin) are contraindicated in WPW/pre-excitation with AF — they may accelerate accessory pathway conduction and precipitate VF. (Rosen's Emergency Medicine)

If AF + HFrEF (EF <40%): Avoid diltiazem/verapamil. Use amiodarone or digoxin for acute rate control; beta-blockers should be avoided until hemodynamically stable.

---

ST-T Changes — Workup Decision

1. Rate-related repolarization changes: ST depression in multiple leads at rapid rates — expected; should improve once rate is controlled
2. Demand ischemia: Tachycardia increasing O₂ demand — usually diffuse ST changes, troponin may rise mildly
3. ACS triggering AF: Focal ST changes (e.g., inferior or anterior), troponin positive → activate ACS protocol, consider cardiology consult for angiography

---

Anticoagulation & Stroke Prevention

Acute Setting

• If AF duration <48 hours and cardioversion planned: can proceed; still give anticoagulation
• If AF duration >48 hours or unknown: anticoagulate for 3–4 weeks before elective cardioversion, OR perform TEE to exclude LA thrombus before urgent cardioversion

CHA₂DS₂-VASc Scoring (this patient)

• Non-valvular AF: Preferred agents are DOACs (apixaban, rivaroxaban, dabigatran, edoxaban)
• Valvular AF (mechanical valve, rheumatic mitral stenosis): warfarin (INR 2–3)

---

Causes of AF to Consider in This Patient

---

Rate vs. Rhythm Control Strategy

• Acute: Rate control is the priority once stability is ensured
• Long-term: Rhythm control via catheter ablation (not anti-arrhythmic drugs) is associated with improved outcomes in AF + heart failure (Rosen's; Goldman-Cecil Medicine)
• For elderly patients with rate-controlled AF and no significant symptoms, rate control alone is a reasonable long-term strategy

---

Disposition

• Persistent respiratory distress / pulmonary congestion
• Ventricular rate not controlled in ED
• Ongoing myocardial ischemia (positive troponin, ischemic ECG changes)
• New-onset AF with hemodynamic compromise
• High-risk features (prior stroke/TIA, CXR pulmonary congestion, long AF duration)

---

Summary Algorithm

65F — Dyspnea + AF with RVR + ST-T changes
        ↓
Is she UNSTABLE? (hypotensive, severe pulmonary edema, altered mental status)
        ↓                          ↓
       YES                         NO
        ↓                          ↓
Synchronized DC             Investigate cause of AF
cardioversion              (ACS? HF? PE? Thyroid?)
                                   ↓
                       Troponin + Echo + CXR + TSH
                                   ↓
                       Rate control: diltiazem IV
                       (if EF reduced → amiodarone or digoxin)
                                   ↓
                       Anticoagulation (CHA₂DS₂-VASc ≥2 → DOAC)
                                   ↓
                       Serial ECG + troponin → rule out ACS
                                   ↓
                       Consider cardioversion if <48h duration
                       (or TEE-guided if >48h)

---

---

Updated Clinical Assessment: 69F — Dyspnea + AF with RVR + T-wave Changes + History of Thyroid Disease + Troponin I Negative

---

Key Updates from New Information

---

Why Thyroid Disease is Now the Central Focus

"Atrial fibrillation may be the first symptom of thyroid hormone excess in older adults." — Braunwald's Heart Disease

---

ECG Findings — Interpretation

• Absent P waves, irregularly irregular QRS, rate >100 bpm
• In thyrotoxicosis: AF with high ventricular rate is classic; catecholamine excess drives AV nodal conduction

• With negative troponin, this is most consistent with:
  1. Rate-related repolarization changes — tachycardia shortens diastole, altered repolarization, T-wave changes in multiple leads
  2. Thyrotoxic cardiomyopathy / thyroid-mediated LV dysfunction — high output state with ventricular strain
  3. Hypokalemia — common with sympathetic excess/thyrotoxicosis
  4. Tachycardia-induced cardiomyopathy if AF is longstanding
• True ACS excluded by negative troponin (though repeat troponin at 3–6 hours is still advisable)

---

Urgent Investigations

Thyroid Panel (PRIORITY)

Cardiac

• Serial ECG (post rate control — do T-wave changes resolve?)
• Repeat troponin at 3–6 hours (confirm negative)
• Echocardiogram (assess LV function, exclude thyrotoxic cardiomyopathy, valvular disease)
• CXR (pulmonary congestion, cardiomegaly)

Labs

• BMP + Mg²⁺ (hypokalemia and hypomagnesemia common in hyperthyroidism, promote AF)
• CBC (infection/sepsis as precipitant)
• If thyroid disease history includes exogenous thyroid hormone (levothyroxine) — check compliance and recent dose changes

---

Management: Thyroid Disease + AF with RVR

Step 1 — Rate Control (Immediate)

• Control ventricular rate
• Block peripheral T4 → T3 conversion (propranolol specifically)
• Attenuate sympathetic hyperactivity (tremor, anxiety, heat intolerance)

⚠️ AVOID AMIODARONE in patients with known thyroid disease — amiodarone causes thyroid dysfunction in 15–20% of patients and can precipitate or worsen thyrotoxicosis. (Miller's Anesthesia; Goldman-Cecil Medicine)

• Increased digitalis clearance
• Decreased drug sensitivity (high Na⁺/K⁺-ATPase levels)
• Reduced parasympathetic tone → Higher doses required; use with caution

---

Step 2 — Treat the Underlying Thyroid Cause (Definitive)

"The first-line treatment of AF and supraventricular tachycardia in patients with thyroid dysfunction should aim primarily to restore a euthyroid state." — Braunwald's Heart Disease

⚠️ Always start antithyroid drugs before iodide — iodide alone may transiently worsen thyrotoxicosis (Barash Clinical Anesthesia)

---

Step 3 — Cardioversion Strategy

• AF frequently reverts spontaneously to sinus rhythm once the patient is rendered euthyroid — this may take weeks
• Wait up to 4 months after normalization of thyroid function before attempting pharmacological or electrical cardioversion
• If sinus rhythm does not return spontaneously within 4 months of euthyroid state → plan for cardioversion with prior anticoagulation/TEE assessment

---

Step 4 — Anticoagulation

Note: Anticoagulation in hyperthyroid AF is somewhat controversial — hyperthyroidism itself increases thrombogenesis (elevated fibrinogen, factor X, von Willebrand antigen). However, the thromboembolic risk must be weighed against bleeding risk.

• Preferred: DOAC (apixaban, rivaroxaban) for non-valvular AF
• Warfarin: Less predictable in hyperthyroidism — thyrotoxicosis increases warfarin sensitivity (accelerated vitamin K-dependent clotting factor catabolism) → monitor INR closely if warfarin is used

---

Watch for Thyroid Storm

---

Summary Algorithm

69F — Dyspnea + AF with RVR + T-wave changes + Thyroid History + Troponin NEGATIVE
                        ↓
         ACS effectively excluded (serial troponin still advised)
                        ↓
             THYROID STATUS = TOP PRIORITY
         Order: TSH + Free T4 + Free T3 STAT
                        ↓
         Immediate Rate Control:
         → Beta-blocker FIRST (propranolol/esmolol/metoprolol)
         → CCB if beta-blocker contraindicated
         → AVOID amiodarone (worsens thyroid dysfunction)
                        ↓
         If TSH suppressed / hyperthyroid confirmed:
         → Start antithyroid drug (methimazole or PTU)
         → Add potassium iodide AFTER antithyroid drug
         → Steroid if storm features present
                        ↓
         Anticoagulation: CHA₂DS₂-VASc ≥2 → DOAC
         (warfarin with close INR monitoring if preferred)
                        ↓
         Cardioversion: Defer until euthyroid state
         achieved (up to 4 months)
                        ↓
         T-wave changes: Monitor serial ECGs
         — expect improvement with rate control
         — persistent changes → echo to assess LV function

---

---

AF Persists Despite Metoprolol + Propranolol — Next Steps

First: Reassess the Situation

This is expected in thyrotoxic AF. The hyperthyroid state amplifies adrenergic stimulation, making rate control harder to achieve than in non-thyroid AF.

---

Immediate Clinical Questions (Answer These First)

1. Is the patient HEMODYNAMICALLY STABLE or UNSTABLE?

---

IF HEMODYNAMICALLY UNSTABLE → Emergency Synchronized DC Cardioversion

"For patients with recent-onset atrial fibrillation and a rapid ventricular response that is producing hypotension, myocardial ischemia, or pulmonary edema, treat with urgent electrical cardioversion." — Tintinalli's Emergency Medicine

DC Cardioversion Protocol

⚠️ In thyrotoxic AF, electrical cardioversion may successfully convert to sinus rhythm, but AF frequently recurs until the underlying hyperthyroid state is corrected. Treating the thyroid is essential.

---

IF HEMODYNAMICALLY STABLE — Escalate Pharmacological Rate Control

Why beta-blockers are failing here:

• Thyrotoxicosis creates an extremely high catecholamine-like state
• The AV node in hyperthyroidism is hypersensitive to adrenergic drive
• Standard doses of metoprolol/propranolol may be insufficient — higher doses or IV route is needed, OR add a second-class agent

Step-Up Options (choose based on LV function):

---

Option A: Add Diltiazem IV (if LV function preserved — EF ≥40%)

Combination of beta-blocker + diltiazem provides dual AV nodal blockade — more effective than either alone. Use with caution — risk of excessive bradycardia and hypotension.

---

Option B: Increase Propranolol Dose / IV Route

• Non-selective (blocks both β1 and β2)
• Also inhibits peripheral T4 → T3 conversion (uniquely beneficial)
• If oral doses have been used, switch to IV propranolol:
  • 0.5–1 mg IV slowly over 10 min, repeat every 5–10 min
  • Target HR <90 bpm

---

Option C: Add Digoxin (especially if LV dysfunction present)

• Loading dose: 0.25–0.5 mg IV, repeat 0.25 mg every 4–6 hours (max 1–1.5 mg/24h)
• Onset: 30–60 min (IV), peak 4–6 hours
• Caveat in hyperthyroidism: increased clearance and decreased sensitivity — higher doses are needed, monitor for toxicity
• Digoxin + beta-blocker together is more effective than either alone

---

Option D: Esmolol Infusion (titratable, short-acting)

---

⚠️ Critical Drug to AVOID: Amiodarone

• Contains 37% iodine by weight
• Can precipitate or dramatically worsen amiodarone-induced thyrotoxicosis (AIT)
• Will make the thyroid disease far harder to manage (Miller's Anesthesia; Goldman-Cecil Medicine)

---

Parallel Actions — Do These Simultaneously

1. Optimize Antithyroid Treatment

• Methimazole or PTU has been started (if not already)
• Consider adding potassium iodide (after antithyroid drug to avoid worsening toxicosis)
• Hydrocortisone 100 mg IV if thyroid storm is suspected

2. Correct Electrolytes

• Hypokalemia and hypomagnesemia — extremely common in hyperthyroidism, promote AF and make rate control harder
• Target: K⁺ >4.0 mEq/L, Mg²⁺ >0.8 mmol/L
• IV KCl + IV MgSO₄ (1–2 g IV over 15 min) if deficient

3. Anticoagulation

• Ensure anticoagulation is active — AF with thyrotoxicosis carries high thromboembolic risk
• DOAC preferred; if not started, begin now

4. Reassess SpO₂ and Work of Breathing

• If SpO₂ falling despite supplemental O₂ → escalate to NIV (CPAP/BiPAP) or prepare for intubation
• Consider urgent echo if LV function unknown

---

Decision Algorithm for This Moment

AF persists — Rate 80–180 bpm — Irregularly Irregular
                    ↓
       Is patient HEMODYNAMICALLY STABLE?
           ↓                    ↓
          NO                   YES
           ↓                    ↓
  SYNCHRONIZED DC         Assess LV Function
  CARDIOVERSION            (Echo / clinical)
  (120–200 J biphasic)         ↓              ↓
  + anticoagulation        EF PRESERVED    EF REDUCED
  + procedural sedation         ↓              ↓
                          Add diltiazem    Digoxin IV +
                          IV + escalate    escalate propranolol
                          propranolol      (avoid diltiazem)
                               ↓
                        Consider esmolol infusion
                        for precise titration
                               ↓
                    Correct K⁺ and Mg²⁺
                    Ensure antithyroid drug started
                    Continue anticoagulation
                               ↓
               If still uncontrolled → Cardiology consult
               Consider elective cardioversion once
               euthyroid state achieved (up to 4 months)

---

What "AF Persisting" Means in Thyrotoxicosis

"Pharmacological or electrical cardioversion should be considered in patients who do not recover normal rhythm spontaneously within 4 months of normalization of thyroid function." — Braunwald's Heart Disease

---

---

AF Reverted to Sinus Rhythm — But Dyspnea Persists

Critical Point: Sinus Rhythm ≠ Problem Solved

---

Why Dyspnea Persists — Differential Diagnosis

1. ⭐ Tachycardia-Induced / Thyrotoxic Cardiomyopathy (Most Likely)

"In patients with longstanding hyperthyroidism and marked sinus tachycardia or atrial fibrillation, low cardiac output, impaired cardiac contractility with a low ejection fraction, and pulmonary congestion can develop — all consistent with heart failure." — Braunwald's Heart Disease

• High resting cardiac output → increased preload to pulmonary circulation
• Pulmonary vascular resistance does NOT fall (unlike systemic) → pulmonary arterial pressure rises
• Right heart strain → elevated JVP, hepatic congestion, peripheral edema
• High output state increases renal sodium reabsorption → volume overload

---

2. Acute Decompensated Heart Failure / Pulmonary Edema

• Precipitated by the prolonged AF with RVR (the heart has been under stress for hours)
• LV filling impaired during AF → back-pressure into pulmonary vasculature
• Post-cardioversion: atrial stunning can temporarily worsen LV filling

---

3. Pulmonary Embolism

• AF itself is a risk for thrombus formation
• Cardioversion can potentially dislodge an atrial thrombus → pulmonary embolism
• If anticoagulation was not given before cardioversion, this risk is elevated
• Signs: sudden onset dyspnea, pleuritic chest pain, tachycardia, hypoxia

---

4. Thyrotoxicosis-Associated Pulmonary Hypertension

"Hyperthyroidism associates with a substantial degree of pulmonary hypertension" — Braunwald's Heart Disease

---

5. Thyrotoxic Skeletal/Respiratory Muscle Weakness

• T3 excess causes proximal myopathy including respiratory muscles
• Patients with hyperthyroidism have impaired cardiopulmonary function during exertion even with normal heart rate
• Dyspnea in this setting is not purely cardiac

---

6. Other causes not to miss

• Pneumonia / infection (precipitated the AF in the first place)
• Pleural effusion (from heart failure or thyroid disease)
• Pericardial effusion (thyroid disease-related)
• Anaemia (thyrotoxicosis associated)
• Beta-blocker overdose → bronchospasm (if patient has occult asthma)

---

Immediate Assessment

Bedside (Do NOW)

Investigations

---

Management Based on Likely Cause

Priority 1 — Oxygenation

---

Priority 2 — If Pulmonary Oedema / Heart Failure (most likely)

"The early administration of an intravenous bolus or infusion of a loop diuretic and, in hypoxemic patients, oxygen are the key first-line treatments." — Goldman-Cecil Medicine

⚠️ Avoid aggressive diuresis if patient is in the thyrotoxic high-output state with low systemic vascular resistance — may precipitate hypotension.

---

Priority 3 — If PE Suspected

---

Priority 4 — Continue Thyroid Treatment

• Ensure antithyroid drug (methimazole/PTU) is running
• Propranolol — continues to be important even in sinus rhythm because it:
  • Controls residual sinus tachycardia
  • Inhibits T4 → T3 peripheral conversion
  • Reduces sympathetic-driven dyspnoea
• Monitor thyroid function regularly until euthyroid

---

Priority 5 — Monitor for AF Recurrence

In thyrotoxicosis, sinus rhythm is often unstable until thyroid status normalises. The patient is at high risk of reverting back to AF.

• Continuous cardiac monitoring
• Maintain adequate beta-blocker dose
• Ensure anticoagulation is active (CHA₂DS₂-VASc ≥2)

---

Summary Algorithm

Sinus Rhythm restored — Dyspnoea persists
                ↓
    ASSESS IMMEDIATELY:
    SpO₂ | RR | BP | Auscultation | JVP
                ↓
    Stabilise Oxygenation First:
    Sit upright → O₂ → CPAP/BiPAP if needed
                ↓
        Crackles + ↑JVP + CXR congestion?
              ↓               ↓
             YES              NO
              ↓               ↓
    ACUTE HEART FAILURE   Consider: PE / Thyrotoxic
    IV Furosemide 40-80mg  pulmonary HTN / Anaemia /
    IV GTN if SBP ≥100     Respiratory muscle weakness
    CPAP
              ↓
    Urgent ECHO (LV function?)
              ↓
    If EF reduced → tachycardia-induced
    cardiomyopathy from prolonged AF/RVR
              ↓
    Continue antithyroid therapy
    (LV function improves once euthyroid + HR controlled)
              ↓
    Continuous monitoring — watch for AF recurrence
    Anticoagulation active

---

Important Perspective

1. Immediate: Residual pulmonary oedema from the AF with RVR episode — the lungs don't clear instantly when sinus rhythm restores
2. Intermediate: Tachycardia-induced LV dysfunction — takes days to weeks to recover with rate control + euthyroid state
3. Underlying: Thyrotoxicosis driving high-output state with pulmonary hypertension and respiratory muscle weakness

"Recognition of this phenomenon is important as treatment aimed at slowing the heart rate or controlling the ventricular response in atrial fibrillation appears to improve left ventricular function, even before initiation of antithyroid therapy." — Braunwald's Heart Disease

---